Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.


Dilemmas in TD in Primary Care

In this episode, Greg Mattingly, MD, and W. Clay Jackson, MD, DipTh , discuss how the use of antipsychotics has changed in primary care patients, how primary care physicians can screen for tardive dyskinesia (TD), and increasing needs for the primary care physician in mental health.

W. Clay Jackson, MD, DipTh
Greg Mattingly, MD
Released: August 20, 2021

Information on this Educational Activity


W. Clay Jackson, MD, DipTh

Assistant Professor of Clinical Family Medicine & Psychiatry
College of Medicine
University of Tennessee
Palliative Care
West Cancer Center
Memphis, Tennessee

W. Clay Jackson, MD, DipTh, has disclosed that he has received consulting fees from AbbVie, Alkermes, Genentech, Otsuka, and Sunovion.
Greg Mattingly, MD

Associate Clinical Professor
Psychiatry, Psychopharmacology
Washington University School of Medicine
St Louis, Missouri
St Charles Psychiatry Associates
St Charles, Missouri

Greg Mattingly, MD, has disclosed that he has received consulting fees from AbbVie, Acadia, Alkermes, Axsome, Eisai, Ironshore, Intracellular, Janssen, Lundbeck, Neos, Neurocrine, Otsuka, Redax, Roche, Rhodes, Sage, Shire, Sunovion, Supernus, Takeda, Teva, and Trispharma; funds for research support from AbbVie, Acadia, Alkermes, Avanir, Axsome, Boehringer Ingelheim, Emalex, Janssen, Medgenics, NLS-1 Pharma AG, Redax, Roche, Sage, Shire, Sunovion, Supernus, Takeda, and Teva; and fees for non-CME/CE services from AbbVie, Alkermes, Eisai, Janssen, Lundbeck, Neurocrine, Otsuka, Sunovion, Supernus, Takeda, and Trispharma.

Program Medium

This program has been made available online.


Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant provided by
Neurocrine Biosciences

Related Content

Dr John M. Kane presents an expert’s guide to tardive dyskinesia, from Clinical Care Options (CCO)

John M. Kane, MD Physicians: maximum of 0.75 AMA PRA Category 1 Credits Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Physician Assistants: maximum of 0.75 hours of AAPA Category I CME credit Released: January 12, 2022 Expired: January 11, 2023

Podcast with Diana Perkins, MD, MPH, and Martha Sajatovic, MD, on the functional and social impact of tardive dyskinesia on the lives of patients, from Clinical Care Options (CCO)

person default Diana O. Perkins, MD, MPH person default Martha Sajatovic, MD Released: January 11, 2022

Dr. Greg Mattingly reviews recent advances in treating schizophrenia, from Clinical Care Options (CCO)

Greg Mattingly, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physician Assistants: maximum of 1.0 hour of AAPA Category I CME credit Social Workers: 1.0 ACE CE Credit Psychologists: 1.0 APA CE Credit Released: January 11, 2022 Expired: January 10, 2023

Sanjay Gupta, MD, on salient research studies of interest relevant to neuroscience, including agitation in dementia, insomnia, antipsychotics in schizophrenia, COVID-19, and provides clinical commentary from Clinical Care Options (CCO)

Sanjay Gupta, MD Released: December 22, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings